Log In or Register to Join The Conversation!
  • This topic has 1 voice and 0 replies.
Viewing 0 reply threads
  • Author
    Posts
    • #18690

      Novartis’s Mayzent has become the first treatment approved by Australia’s Therapeutic Goods Administration (TGA) for the treatment of SPMS. Read more about it here.

      Are you excited about this news?

Viewing 0 reply threads
  • You must be logged in to reply to this topic.
Copyright © 2017-2020 All rights reserved.

©2020 KLEO Template a premium and multipurpose theme from Seventh Queen

CONTACT US

We're not around right now. But you can send us an email and we'll get back to you, asap.

Sending
or

Log in with your credentials

or    

Forgot your details?

or

Create Account